Janet Woodcock (AP Images)
April 14, 2021 01:45 PM EDTUpdated 02:08 PM
Pharma
FDA+

Janet Wood­cock on if the FDA is get­ting tougher on drug re­views: ‘I don’t think so’

Zachary Brennan

Senior Editor

Fol­low­ing a re­cent string of set­backs for some drug de­vel­op­ers, act­ing FDA com­mis­sion­er Janet Wood­cock said Wednes­day that she does not think the FDA is …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times